![]() Biocartis Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. | ||
Founding Date | Founding Date 1985 | Founding Date 2007 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Marlborough, US HQ Macquarie Park, AU Wien, AT Seraing, BE Vilvoorde, BE Zaventem, BE São Paulo, BR see more | Locations Jersey City, US HQ Meadowbrook, AU Mechelen, BE Sofia, BG Huechuraba, CL Zagreb, HR Espoo, FI see more |
Employees | Employees 7,070 | Employees 52614% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $4.1b (FY, 2025) | Revenue (est.) €47.4m (FY, 2023) |
Cost of goods | Cost of goods $2b (FY, 2025) | Cost of goods €12.4m (FY, 2023) |
Gross profit | Gross profit $2.1b (FY, 2025) | Gross profit €35.3m (FY, 2023) |
Net income | Net income $565.7m (FY, 2025) | Net income €18.4m (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 450m | Total funding raised $ 321.2m |

Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
View company